Mycobacterium tuberculosis Inactivation

Dr. Roopa Viswanathan, Study Director
Qualilife Diagnostics, India
Full Report


To evaluate the efficacy of the Protect 200 on reducing Mycobacterium tuberculosis.


The Protect 200 unit was placed inside a 68 litre plastic enclosure. The plastic enclosure and test set up was placed inside a biosafety cabinet. Clinical isolate of Mycobacterium tuberculosis was aseptically transferred into a sterile mycobacteria growth indicator tube (MGIT) and Lowenstein-Jensen (LJ) medium.

Summary of Results

The air sample collected from the test after being exposed to the Protect 200 showed no growth of Mycobacterium tuberculosis. This shows that the device has effectively rendered all airborne Mycobacterium tuberculosisnon-viable.

Contact Us

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750